signal is mediated by the ADPR-cyclse metabolite, cADPR. Moreover, among structurally similar compounds tested, the compound inhibited most potently the cADPR production and Ca 2+ signal induced by CaSR. These findings provide evidence for existence of a distinct ADPR-cyclase in the kidney and basis for the development of tissue specific inhibitors.
Introduction
ADP-ribosyl cyclase (ADPR-cyclase) is widely distributed and plays a critical role in regulation of intracellular Ca 2+ concentration ([Ca 2+ ]i) via cyclic ADP-ribose (cADPR) production (Guse et al., 1999; Galione et al., 2000; Lee, 2001) . The metabolite cADPR is known to increase [Ca 2+ ]i by releasing from intracellular Ca 2+ stores or by Ca 2+ influx through plasma membrane Ca 2+ channels in a variety of cells (Guse et al., 1999; Galione et al., 2000; Lee, 2001; Partida-Sanchez et al., 2001) . Studies have indicated that a Zn 2+ -sensitive and reducing agent-insensitive ADPR-cyclase(s), which differs from CD38 or Aplysia californica ADPRcyclase, is present in brain, heart, kidney, arterial smooth muscle cells, and bone marrow cells (Hirata et al., 1994; de Toledo et al., 2000; Ceni et al., 2003; Zielinska et al., 2004; Xie et al., 2005) . A study with mice disrupted CD38 gene has demonstrated that formation of cADPR is not reduced greatly in mouse kidney, brain, and heart (PartidaSanchez et al., 2001) , suggesting that ADPRcyclases other than CD38 exist. However, the ADPR-cyclase(s) present in these tissues has not been cloned, and the cADPR antagonistic derivatives such as 8-Br-cADPR and 8-NH2-cADPR do not distinguish the Ca 2+ signals induced by the unidentified ADPR-cyclase or CD38 (Walseth and Lee, 1993) . Moreover, specific inhibitors of ADPRDiscovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose cyclases have neither been found nor synthesized.
As bioactive small-molecules capable of inducing a specific phenotype serve as tools to probe the functions of protein and signaling pathways (Schreiber, 1998; Kwon, 2003) , we expect that specific ADPR-cyclase inhibitors would be useful for demonstrating the existence of kidney ADPR-cyclase, for providing specific tools to distinguish the ADPRcyclase from other ones originated from different tissues, and as potential lead molecules targeting the ADPR-cyclase for therapeutic benefit. To this end, we partially purified ADPR-cyclase from rat kidney, characterized, and screened a chemical library. Here, we report the discovery of a bioactive smallmolecule inhibitor of the kidney ADPR-cyclase.
Materials and Methods

Materials
Anti-human CD3 monoclonal antibody (clone OKT3) was obtained from eBioscience (San Diego, CA). Nicotinamide 1,N 6 -ethenoadenine dinucleotide ( -NAD + ), nicotinamide guanine dinucleotide (NGD + ), protease inhibitors, heparin-agarose and other chemicals were from Sigma-Aldrich (St. Louis, Mo). Q-Sepharose, Chelating-Sepharose, and CM-Sepharose were purchased from Amersham Biosciences (Piscataway, NJ). 4,4'-Dihydroxyazobenzene (DHAB) and chemical library were purchased from ComGenex (Budapest, Hungary) and Chembridge (San Diego, CA).
Partial purification of ADPR-cyclase from rat kidney
Kidneys from Sprague-Dawley rats weighing 250-300 g were washed with ice-cold PBS, minced in a lysis buffer (50 mM HEPES buffer, pH 7.2, 150 mM NaCl, 10% Glycerol, and 1 mM PMSF) and homogenized with a Teflon glass homogenizer in an ice bath. After centrifugation at 500 × g for 10 min, the supernatant was centrifuged at 100,000 × g for 1 h. Pellets obtained were solubilized with 1% Triton X-100 in the lysis buffer for 1 h. After centrifugation at 100,000 x g for 1 h, the extract was used to purify ADPR-cyclase. We found that ADPR-cyclase did not bind to CM-Sepharose and heparin-agarose and therefore, they were used for the negative purification. The flow-through fractions from these columns were loaded onto Cu 2+ -chelating Sepharose, washed with five column volume of the lysis buffer containing 0.1% Triton X-100, and eluted with 200 mM imidazole in the same buffer. Overall yield was approximately 15% with 64-fold purification.
Assays for ADPR-cyclase and cADPR-hydrolase assays Specific ADPR-cyclase activity was determined by measuring cyclic GDP-ribose (cGDPR) or etheno-ADP-ribose ( -ADPR) fluorometrically using NGD + or -NAD + as a substrate (Greaff et al., 1994) . Samples were incubated in the presence of 200 M NGD + or -NAD + with and without an appropriate agent in an assay buffer (25 mM HEPES, pH 7.4, 100 mM NaCl, and 0.1% Triton X-100) in a 50 l-final volume. The reaction mixture was incubated at 37 o C for 10 min. The reaction was stopped by adding 50 l trichloroacetic acid (10%). The samples were centrifuged at 21,000 × g for 10 min and the supernatant (80 l) was diluted with 920 l of 100 mM sodium phosphate buffer (pH 7.2). Fluorescence of cGDPR or -ADPR in the solution was determined at excitation/emission wavelengths of 297/410 nm (HITACHI F-2000 fluorescence spectrophotometer). cADPR-hydrolase activity was determined by incubating cADPR with ADPR-cyclase or CD38 at 37 o C for 20 min. Hydrolysis of cADPR was analyzed by high performance liquid chromatography as described (White et al., 2000) .
Chemical library screening
Using a chemical library of approximately 10,000 compounds, the screening of ADPR-cyclase inhibitor was conducted in the reaction mixture with partially purified rat kidney ADPR-cyclase, chemical compound, and 200 M -NAD + in the assay buffer in a 50 l-final volume. Formation of cADPR was determined as described above after incubation of the reaction mixtures at room temperature for 60 min. Concentration of compounds used in all enzyme inhibitory assays was 200 M unless otherwise indicated.
Cell culture
Mouse kidney mesangial cells (MMC) were kindly provided by S. H. Cha (Kwak et al., 2005) and cultured in DMEM supplemented 5% heat inactivated FBS, 0.25 g/ml amphotericin B, penicillin (100 U/ml), and streptomycin (100 U/ml). Jurkat T cells were obtained from American Tissue Culture Collection (ATCC, Manassas, VA) and maintained in RPMI 1640 supplemented with 10% FBS and antibiotics described above. The cells were maintained in a humidified incubator at 37 o C in the presence of 5% CO2 and 95% air.
Measurement of intracellular cADPR concentration [cADPR] i
[cADPR]i was measured using a cyclic enzymatic assay as described previously (Graeff and Lee, 2002) . Aplysia californica ADPR-cyclase was purified from sea urchin egg according to the method described (Lee and Aarhus, 1991) .
Measurement of [Ca
2+
] i Changes in [Ca 2+ ]i in MMC and Jurkat T cells were determined as described previously (Kim et al., 2006) . Briefly, MMC cultured on confocal dishes for 48 h or Jurkat T cells seeded on 100 g/ml poly L-lysine-coated confocal dishes at a concentration of 10 4 cells/dish were washed with Hank's balanced salt solution (HBSS) (2 mM CaCl2, 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM D-glucose, and 20 mM HEPES, pH 7.3) and then loaded with 5 M Fluo3 AM (Molecular Probe, Eugene, OR). Changes in Ca 2+ fluorescence were determined at 488 nm/530 nm (excitation/emission) by air-cooled argon laser system. [Ca 2+ ]i was calculated using a Kd of 325 nM for Fluo3 AM by the method of Tsien et al. (1982) .
Cell proliferation assay
MMC was seeded at a concentration of 5 × 10 3 cells/well on a 12-well plate. After incubating for 1 day, 10 mM [Ca 2+ ] o was treated for 2 days (Kwak et al., 2005) . The cells were then detached using 0.25% trypsin-EDTA, and the number of cells was counted after trypan blue staining to exclude dead cells.
Statistical analysis
Data represent means ± standard error of the mean (SEM) of at least three separate experiments.
Statistical analysis was performed using Student's t-test. A value of P ＜ 0.05 was considered significant.
Results and Discussion
Characterization of ADPR-cyclase from rat kidney
As a confirmation for the study, we firstly examined whether kidney ADPR-cyclase exhibits different biochemical properties from those of CD38. Zinc ion is known to stimulate the cADPR forming cyclase activity of CD38 but inhibits its cADPR-hydrolase activity and a reducing agent, 1,4-dithiothreitol (DTT) has been shown to inhibit both ADPR-cyclase and cADPR-hydrolase activities (Kukimoto et al., 1996) . The effects of these molecules on the kidney ADPR-cyclase and CD38 were evaluated. Zinc stimulated the cyclase activity of CD38 but inhibited kidney ADPR-cyclase activity ( Figure 1A ). On the other hand, DTT inhibited the cyclase activity of CD38 but exhibited no effect on the kidney ADPRcyclase ( Figure 1B) . When cADPR-hydrolase activity of the kidney ADPR-cyclase was determined, we found that cADPR-hydrolase activity of the kidney enzyme was not detected whereas CD38 exhibited cADPR-hydrolase activity that was inhibited by Zn 2+ (data not shown). These results demonstrate that the kidney ADPR-cyclase is distinct from CD38 in biochemical properties.
Identification of 4,4'-dihydroxy azobenzene (DHAB) as a kidney ADPR-cyclase inhibitor
Having known that kidney ADPR-cyclase differs Figure 1 . Effects of Zn 2+ and DTT on the activity of rat kidney ADPR-cyclase and CD38. Partially purified rat kidney ADPR-cyclase (10 g/assay) or recombinant human CD38 (10 g/assay) was incubated with various concentrations of ZnCl2 (A), and DTT (B) at 37 o C for 10 min and the ADPR-cyclase activity was measured by using NGD + as the substrate.
from CD38, we screened a chemical library of approximately 10,000 compounds for small-molecule inhibitors of the kidney ADPR-cyclase. This screen resulted in the selection of DHAB as a smallmolecule inhibitor (Figure 2A) . The compound was able to inhibit generation of cGDPR and -ADPR from NGD + and -NAD + , respectively, by the kidney ADPR-cyclase in a concentration-dependent manner. These data suggest that the compound may bind to the active site of the enzyme. Half maximal inhibition (IC 50 ) of the enzyme activity was approximately 100 M ( Figure 2B ). CD38 and ADPRcyclases purified partially from rat brain, heart, and spleen tissues were insensitive to DHAB at 200 M ( Figure 2C ).
Stimulation of extracellular calcium ion ([Ca
2+
] o )-sensing receptor (CaSR) in mouse mesangial cells (MMC) produces cADPR and a long-lasting Ca 2+ signal Inhibitory potency of DHAB on the ADPR-cyclase activity is critical for studying the signaling or inducing phenotype in a cell-based system. In MMC, an ADPR-cyclase activating receptor has not been identified. However, a number of G protein-coupled receptors (GPCRs) have been shown to utilize ADPR-cyclase in regulation of [Ca 2+ ]i (Higashida et al., 1999; Boittin et al., 2003; Ge et al., 2003; Sternfeld et al., 2003; Fellner and Arendshorst, 2005) . We examined several ligands of GPCRs, which are known to stimulate cADPR production in various cells upon binding to the cognate receptor. Among them, stimulation of CaSR with [Ca 2+ ]o resulted in a significant increase of [cADPR]i, ( Figure  3A ) and a generation of long-lasting increase of [Ca 2+ ]i, a burst Ca 2+ rise followed by a sustained Ca 2+ rise that was gradually decreased ( Figure 3B ). The sustained Ca 2+ signal, but not the initial burst Ca 2+ rise, was blocked by pre-treatment with an antagonistic cADPR, 8-Br-cADPR ( Figure 3C ). On the basis of these results that stimulation of CaSR activates ADPR-cyclase in MMC, we evaluated DHAB as a possible candidate inhibitor of ADPRcyclase. This compound was able to inhibit [Ca 2+ ]omediated later sustained elevation of [Ca 2+ ]i but not the initial rise of [Ca 2+ ]i in a dose-dependent manner ( Figure 4A-G) . Further, [Ca 2+ ]o-induced production of cADPR was also blocked by pre-treatment of DHAB in a concentration-dependent manner ( Figure 4H ). IC50 was approximately 2.5 nM. In addition, since it has been reported that CaSR-mediated Ca 2+ signal is involved in MMC proliferation (Kwak et al., 2005) , we examined whether DHAB inhibits the [Ca 2+ ]oinduced MMC proliferation. As presented in Figure  4I , the [Ca 2+ ]o-induced increment of proliferation was also inhibited by DHAB in a similar range of concentrations observed in the inhibition of the sustained Ca 2+ signal, suggesting that cADPR-induced sustained6 Ca 2+ signal regulates MMC proliferation.
An efficacy of DHAB for inhibition of kidney ADPR-cyclase was further evaluated utilizing DAHB o C for 1 h. (C) Effects of DHAB on human CD38, rat brain, heart, spleen, and kidney ADPR-cyclase. The mean ± SEM of three independent experiments is shown. *Control versus DHAB, P ＜ 0.001. analogs, 2,2'-dihydroxybenzene and azobenzene, and structurally similar compounds, resveratrol and piceatannol that are known to activate SIRT1 activity, which uses NAD as a cofactor (Howitz et al., 2003) . Production of cADPR and the later sustained Ca 2+ signal in response to [Ca 2+ ]o were inhibited with different efficacy by these small molecules ( Table  1) . As expected, among these small molecules, DAHB showed the strongest inhibitory potency. The order of IC50 was DAHB > resveratrol ＞ azobenzene = piceatannol ＞2,2'-dihydroxy azobenzene. These observations suggest that the biphenyl moiety but ]o-induced production of cADPR was blocked by pre-treatment of DHAB in a concentration-dependent manner. (I) DHAB inhibits [Ca 2+ ]o-induced increment of proliferation of MMC in a dose-dependent manner. The mean ± SEM of three independent experiments is shown. *Control versus 10 mM CaCl2, P ＜ 0.001; **10 mM CaCl2 versus 10 mM CaCl2 plus DHAB, P ＜ 0.001. not the azo bond and position of hydroxyl group affect the binding of the inhibitor to the enzyme.
Taken together, these data show that DHAB inhibits cADPR production stimulated by CaSR in MMC at ≤ 5 nM and is far more potent in cell-based system than in vitro. Although the reasons for the different efficacy of the DHAB are not clearly understood, it might be due to the environment of the enzyme location such as membranes versus detergent or due to nonspecific hindrance of other proteins in the enzyme preparation. It is also possible that the kidney enzyme is a transmembrane protein as CD38 is, so that accessibility of DAHB to the enzyme in the cell system is far greater than that in detergent. A prototype of ADPRcyclases, CD38 is a type II transmembrane protein in which the active site is located at the extracellular domain (Han et al., 2000; . In fact, the kidney enzyme was found in plasma membrane rich fraction but not cytosol (data not sown).
Specificity of DHAB
Above results obtained from in vitro study indicated that DHAB is specific for the kidney ADPR-cyclase. To evaluate this finding further, we utilized a human T cell-derived cell line, Jurkat T cell. Jurkat T cells express exclusively CD38 that is regulated by CD3/TCR (Zubiaur et al., 1997) . Treatment of Jurkat T cells with OKT3, which is a ligand for CD3/TCR, showed a typical biphasic increase of [Ca 2+ ] i , an initial peak rise followed by a sustained rise ( Figure  5A ). Pre-treatment with 8-Br-cADPR inhibited only the sustained Ca 2+ rise ( Figure 5B ). In contrast, DHAB did not show any effects on OKT3-mediated Ca 2+ rise even at 10 M ( Figure 5C ). Effects of these agents on OKT3-induced Ca 2+ signal was summarized in Figure 5D and 5E. Supporting the observations, OKT3-induced cADPR production was not blocked by pre-treatment with DHAB ( Figure 5F ). In the present study, we have discovered a small and potent molecule, DHAB, that inhibits specifically the kidney ADPR-cyclase at ≤ 5 nM. The discovery of the specific inhibitor for the enzyme enables us to provide further evidence that there are ADPRcyclases different from CD38. More importantly, our data provide the basis for the discovery of bioactive small-molecule ADPR-cyclase inhibitors, utilizing partially purified enzyme and cell-based system. Benefits of the kidney ADPR-cyclase specific inhibitor are several folds: use of DHAB may facilitate understanding of kidney functions involving regulation of Ca 2+ homeostasis; the inhibitor may help to understand pathogenesis of the kidney; this compound can be the basis for development of tissue specific inhibitors of ADPR-cyclases; finally, the compound may be applied to therapeutic purposes for prevention and management of human kidney diseases.
